Skip to main content
Top
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Understanding attitudes, barriers and challenges in a small island nation to disease and partner notification for HIV and other sexually transmitted infections: a qualitative study

Authors: O Peter Adams, Anne O Carter, Lynda Redwood-Campbell

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

In Barbados sexually transmitted infections (STIs) including HIV are not notifiable diseases and there is not a formal partner notification (PN) programme. Objectives were to understand likely attitudes, barriers, and challenges to introducing mandatory disease notification (DN) and partner notification (PN) for HIV and other STIs in a small island state.

Methods

Six key informants identified study participants. Interviews were conducted, recorded, transcribed and analysed for content using standard methods.

Results

Participants (16 males, 13 females, median age 59 years) included physicians, nurses, and representatives from governmental, youth, HIV, men’s, women’s, church, and private sector organisations.
The median estimated acceptability by society of HIV/STI DN on a scale of 1 (unacceptable) to 5 (completely acceptable) was 3. Challenges included; maintaining confidentiality in a small island; public perception that confidentiality was poorly maintained; fear and stigma; testing might be deterred; reporting may not occur; enacting legislation would be difficult; and opposition by some opinion leaders.
For PN, contract referral was the most acceptable method and provider referral the least. Contract referral unlike provider referral was not “a total suspension of rights” while taking into account that “people need a little gentle pressure sometimes”. Extra counselling would be needed to elicit contacts or to get patients to notify partners. Shame, stigma and discrimination in a small society may make PN unacceptable and deter testing. With patient referral procrastination may occur, and partners may react violently and not come in for care. With provider referral patients may have concerns about confidentiality including neighbours becoming suspicious if a home visit is used as the contact method. Successful contact tracing required time and effort. With contract referral people may neither inform contacts nor say that they did not.
Strategies to overcome barriers to DN and PN included public education, enacting appropriate legislation to allow DN and PN, good patient counselling and maintaining confidentiality.

Conclusions

There was both concern that mandatory DN and PN would deter testing and recognition of the benefits. Public and practitioner education and enabling legislation would be necessary, and the public needed to be convinced that confidentiality would be maintained.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hogben M, McNally T, McPheeters M, Hutchinson AB. The effectiveness of HIV partner counseling and referral services in increasing identification of HIV-positive individuals a systematic review. Am J Prev Med. 2007;33(2 Suppl):S89–100.CrossRefPubMed Hogben M, McNally T, McPheeters M, Hutchinson AB. The effectiveness of HIV partner counseling and referral services in increasing identification of HIV-positive individuals a systematic review. Am J Prev Med. 2007;33(2 Suppl):S89–100.CrossRefPubMed
3.
go back to reference Ferreira A, Young T, Mathews C, Zunza M, Low N. Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database Syst Rev. 2013;10, CD002843. Ferreira A, Young T, Mathews C, Zunza M, Low N. Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database Syst Rev. 2013;10, CD002843.
5.
go back to reference Centers for Disease Control and Prevention. CDC guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR. 1999;48(RR13):1–31. http://www.cdc.gov/mmwr/PDF/rr/rr4813.pdf. Accessed 27 April 2015. Centers for Disease Control and Prevention. CDC guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR. 1999;48(RR13):1–31. http://​www.​cdc.​gov/​mmwr/​PDF/​rr/​rr4813.​pdf. Accessed 27 April 2015.
6.
go back to reference Valdiserri RO, Janssen RS, Buehler JW, Fleming PL. The context of HIV/AIDS surveillance. J Acquir Immune Defic Syndr. 2000;25 Suppl 2:S97–104.CrossRefPubMed Valdiserri RO, Janssen RS, Buehler JW, Fleming PL. The context of HIV/AIDS surveillance. J Acquir Immune Defic Syndr. 2000;25 Suppl 2:S97–104.CrossRefPubMed
7.
go back to reference Nakashima AK, Horsley R, Frey RL, Sweeney PA, Weber JT, Fleming PL. Effect of HIV reporting by name on use of HIV testing in publicly funded counseling and testing programs. JAMA. 1998;280(16):1421–6.CrossRefPubMed Nakashima AK, Horsley R, Frey RL, Sweeney PA, Weber JT, Fleming PL. Effect of HIV reporting by name on use of HIV testing in publicly funded counseling and testing programs. JAMA. 1998;280(16):1421–6.CrossRefPubMed
8.
go back to reference Tesoriero JM, Battles HB, Heavner K, Leung SY, Nemeth C, Pulver W, et al. The effect of name-based reporting and partner notification on HIV testing in New York State. Am J Public Health. 2008;98(4):728–35.CrossRefPubMedPubMedCentral Tesoriero JM, Battles HB, Heavner K, Leung SY, Nemeth C, Pulver W, et al. The effect of name-based reporting and partner notification on HIV testing in New York State. Am J Public Health. 2008;98(4):728–35.CrossRefPubMedPubMedCentral
9.
go back to reference Jayaraman GC, Preiksaitis JK, Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. CMAJ. 2003;168(6):679–82.PubMedPubMedCentral Jayaraman GC, Preiksaitis JK, Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. CMAJ. 2003;168(6):679–82.PubMedPubMedCentral
10.
go back to reference Infuso A, Hamers F, Downs AM, Alix J. HIV reporting in Western Europe: national systems and first European data. Euro Surveillance. 2000;5(2):13–7.PubMed Infuso A, Hamers F, Downs AM, Alix J. HIV reporting in Western Europe: national systems and first European data. Euro Surveillance. 2000;5(2):13–7.PubMed
11.
go back to reference Gertig DM, Marion SA, Schechter MT. Estimating the extent of underreporting in AIDS surveillance. AIDS. 1991;5(10):1157–64.CrossRefPubMed Gertig DM, Marion SA, Schechter MT. Estimating the extent of underreporting in AIDS surveillance. AIDS. 1991;5(10):1157–64.CrossRefPubMed
12.
go back to reference Konowitz PM, Petrossian GA, Rose DN. The underreporting of disease and physicians’ knowledge of reporting requirements. Public Health Rep. 1984;99(1):31–5.PubMedPubMedCentral Konowitz PM, Petrossian GA, Rose DN. The underreporting of disease and physicians’ knowledge of reporting requirements. Public Health Rep. 1984;99(1):31–5.PubMedPubMedCentral
13.
go back to reference Fox DM. From TB to AIDS: value conflicts in reporting disease. Hastings Cent Rep. 1986;16(6):suppl 11–6.CrossRef Fox DM. From TB to AIDS: value conflicts in reporting disease. Hastings Cent Rep. 1986;16(6):suppl 11–6.CrossRef
16.
go back to reference Landis SE, Schoenbach VJ, Weber DJ, Mittal M, Krishan B, Lewis K, et al. Results of a randomized trial of partner notification in cases of HIV infection in North Carolina. N Engl J Med. 1992;326(2):101–6.CrossRefPubMed Landis SE, Schoenbach VJ, Weber DJ, Mittal M, Krishan B, Lewis K, et al. Results of a randomized trial of partner notification in cases of HIV infection in North Carolina. N Engl J Med. 1992;326(2):101–6.CrossRefPubMed
17.
go back to reference Macke BA, Maher JE. Partner notification in the United States: an evidence-based review. Am J Prev Med. 1999;17(3):230–42.CrossRefPubMed Macke BA, Maher JE. Partner notification in the United States: an evidence-based review. Am J Prev Med. 1999;17(3):230–42.CrossRefPubMed
18.
go back to reference Apoola A, Radcliffe KW, Das S, Robshaw V, Gilleran G, Kumari BS, et al. Patient preferences for partner notification. Sex Transm Infect. 2006;82(4):327–9.CrossRefPubMedPubMedCentral Apoola A, Radcliffe KW, Das S, Robshaw V, Gilleran G, Kumari BS, et al. Patient preferences for partner notification. Sex Transm Infect. 2006;82(4):327–9.CrossRefPubMedPubMedCentral
19.
go back to reference Hogben M, St Lawrence JS, Montano DE, Kasprzyk D, Leichliter JS, Phillips WR. Physicians’ opinions about partner notification methods: case reporting, patient referral, and provider referral. Sex Transm Infect. 2004;80(1):30–4.CrossRefPubMedPubMedCentral Hogben M, St Lawrence JS, Montano DE, Kasprzyk D, Leichliter JS, Phillips WR. Physicians’ opinions about partner notification methods: case reporting, patient referral, and provider referral. Sex Transm Infect. 2004;80(1):30–4.CrossRefPubMedPubMedCentral
20.
go back to reference Passin WF, Kim AS, Hutchinson AB, Crepaz N, Herbst JH, Lyles CM. A systematic review of HIV partner counseling and referral services: client and provider attitudes, preferences, practices, and experiences. Sex Transm Dis. 2006;33(5):320–8.CrossRefPubMed Passin WF, Kim AS, Hutchinson AB, Crepaz N, Herbst JH, Lyles CM. A systematic review of HIV partner counseling and referral services: client and provider attitudes, preferences, practices, and experiences. Sex Transm Dis. 2006;33(5):320–8.CrossRefPubMed
21.
go back to reference Kumar A, Waterman I, Kumari G, Carter AO. Prevalence and correlates of HIV serostatus disclosure: a prospective study among HIV-infected postparturient women in Barbados. AIDS Patient Care STDS. 2006;20(10):724–30.CrossRefPubMed Kumar A, Waterman I, Kumari G, Carter AO. Prevalence and correlates of HIV serostatus disclosure: a prospective study among HIV-infected postparturient women in Barbados. AIDS Patient Care STDS. 2006;20(10):724–30.CrossRefPubMed
23.
go back to reference Adams OP, Carter AO, Prussia P, McIntyre G, Branch SL. Risk behaviour, healthcare access and prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoeae in a population-based sample of adults in Barbados. Sex Transm Infect. 2008;84(3):192–4.CrossRefPubMed Adams OP, Carter AO, Prussia P, McIntyre G, Branch SL. Risk behaviour, healthcare access and prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoeae in a population-based sample of adults in Barbados. Sex Transm Infect. 2008;84(3):192–4.CrossRefPubMed
24.
go back to reference Ministry of Health. Barbados HIV surveillance Bulletin 2011. Barbados: Ministry of Health; 2011. Ministry of Health. Barbados HIV surveillance Bulletin 2011. Barbados: Ministry of Health; 2011.
25.
go back to reference Adams OP, Carter AO. Feasibility of a population based survey on HIV prevalence in Barbados, and population preference for sample identification method. Open AIDS J. 2010;4:84–7.CrossRefPubMedPubMedCentral Adams OP, Carter AO. Feasibility of a population based survey on HIV prevalence in Barbados, and population preference for sample identification method. Open AIDS J. 2010;4:84–7.CrossRefPubMedPubMedCentral
26.
go back to reference Kumar A, Kilaru KR, Forde S, Roach TC. Changing HIV infection-related mortality rate and causes of death among persons with HIV infection before and after the introduction of highly active antiretroviral therapy: analysis of all HIV-related deaths in Barbados, 1997-2005. J Int Assoc Physicians AIDS Care (Chic). 2006;5(3):109–14.CrossRef Kumar A, Kilaru KR, Forde S, Roach TC. Changing HIV infection-related mortality rate and causes of death among persons with HIV infection before and after the introduction of highly active antiretroviral therapy: analysis of all HIV-related deaths in Barbados, 1997-2005. J Int Assoc Physicians AIDS Care (Chic). 2006;5(3):109–14.CrossRef
27.
go back to reference Clark JP. How to peer review a qualitative manuscript. In: Godlee F, Jefferson T, editors. Peer Review in Health Sciences, 2nd ed. London: BMJ Books; 2003. p. 219–35. Clark JP. How to peer review a qualitative manuscript. In: Godlee F, Jefferson T, editors. Peer Review in Health Sciences, 2nd ed. London: BMJ Books; 2003. p. 219–35.
28.
go back to reference Hayter M. Confidentiality and the acquired immune deficiency syndrome (AIDS): an analysis of the legal and professional issues. J Adv Nurs. 1997;25(6):1162–6.CrossRefPubMed Hayter M. Confidentiality and the acquired immune deficiency syndrome (AIDS): an analysis of the legal and professional issues. J Adv Nurs. 1997;25(6):1162–6.CrossRefPubMed
29.
go back to reference Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Am J Epidemiol. 2002;155(9):866–74.CrossRefPubMed Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Am J Epidemiol. 2002;155(9):866–74.CrossRefPubMed
Metadata
Title
Understanding attitudes, barriers and challenges in a small island nation to disease and partner notification for HIV and other sexually transmitted infections: a qualitative study
Authors
O Peter Adams
Anne O Carter
Lynda Redwood-Campbell
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1794-2

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue